/ December 4, 2025 Tesla’s equity surged approximately 4% on Thursday, fueled by a significant policy shift in Washington. The rally followed reports that Commerce Secretary Howard Lutnick met with robotics industry CEOs and that the administration is preparing a substantial push to bolster the sector through an executive order. This governmental focus arrives as Tesla’s core electric vehicle business faces headwinds, raising the question: could the company’s “Optimus” humanoid robot project become its next major catalyst? A Divided Street: Valuation Concerns Clash with Robotics Optimism The market’s reaction highlights a deep divide among investors. On one side, proponents point to Tesla’s positioning within a newly prioritized industry. The U.S. Commerce Department confirmed that robotics and advanced manufacturing are central to plans for reshoring critical production. According to Politico, an executive order aimed at accelerating robotics innovation is slated for 2026, with the Department of Transportation set to establish a dedicated robotics task force before year’s end. This aligns with Tesla’s ambitions for Optimus, a humanoid robot designed for manufacturing, service industries, and consumer markets, explicitly avoiding military or police applications. RBC Capital Markets reinforced its “Outperform” rating on Tesla with a $500 price target on Thursday, citing the company’s leadership potential in this emerging field. However, prominent skeptic Michael Burry of “The Big Short” fame offers a stark counterpoint. In his newsletter, Cassandra Unchained, he labeled Tesla as “ridiculously overvalued.” He criticized its price-to-earnings ratio of approximately 298 (versus 23.5 for the S&P 500) and a price-to-sales ratio of 16 (compared to sub-1 figures for Toyota and GM). Burry also highlighted concerns over Elon Musk’s proposed compensation package, valued at one trillion dollars, which could lead to further shareholder dilution. Analyst sentiment reflects this split. Of 44 firms surveyed, 9 recommend selling the stock, 13 advise holding, and 21 suggest buying. The average price target stands near $399, notably below the current trading level around $450.